What is Cosmos Health's operating income?

Cosmos Health's total operating income in 2025 was -$16.70 million, based on the following breakdown: Total Gross Profit: $7.90 million Total Operating Expenses: $24.60 million

Cosmos Health (COSM) Financials

$0.26 -0.02 (-8.09%)

As of 01:52 PM Eastern

Compare

Annual Income Statements for Cosmos Health

This table shows Cosmos Health's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-6.69	-0.60	-6.21	9.05	-3.30	0.82	-16	-64	-26	-22	-19
Consolidated Net Income / (Loss)	-6.69	-0.60	-6.21	-9.06	-3.30	0.82	-7.96	-14	-19	-16	-19
Net Income / (Loss) Continuing Operations	-6.69	-0.60	-6.21	9.05	-3.30	1.58	-7.96	-12	-19	-16	-19
Total Pre-Tax Income	-6.69	-0.60	-6.21	-9.04	-3.12	1.20	-7.85	-13	-19	-16	-19
Total Operating Income	-0.44	-0.20	-4.87	-1.23	-0.26	2.71	-4.53	-7.47	-22	-16	-17
Total Gross Profit	0.05	0.60	1.96	2.41	3.66	8.06	8.33	5.96	4.35	4.31	7.90
Total Revenue	0.53	6.76	30	37	40	55	56	50	53	54	65
Operating Revenue	0.53	6.76	30	37	40	55	56	50	53	54	65
Total Cost of Revenue	0.48	6.15	28	35	36	47	48	44	49	50	57
Operating Cost of Revenue	0.48	6.15	28	35	36	47	48	44	49	50	57
Total Operating Expenses	0.49	0.80	6.83	3.64	3.92	5.35	13	13	26	20	25
Selling, General & Admin Expense	0.49	0.79	4.85	3.59	3.29	2.10	9.21	10	20	12	16
Marketing Expense	-	-	-	-	0.23	0.76	0.73	0.63	1.20	0.35	0.15
Research & Development Expense	-	-	-	-	-	-	-	-	0.16	0.53	0.52
Depreciation Expense	0.01	0.01	0.03	0.04	0.39	0.40	0.45	0.19	0.61	1.25	1.37
Other Operating Expenses / (Income)	-	-	-	-	-	2.08	2.47	2.43	4.55	5.69	6.78
Impairment Charge	-	0.00	1.95	-	-	-	-	-	0.00	0.29	0.16
Total Other Income / (Expense), net	-6.25	-0.40	-1.33	-7.81	-2.86	-1.52	-3.31	-5.58	3.29	-0.64	-2.44
Interest Expense	0.09	0.21	1.64	-8.22	-	2.73	2.97	3.97	-1.04	1.01	2.55
Interest & Investment Income	-6.15	-	0.00	2.50	-	-0.03	0.05	0.24	0.67	0.41	0.40
Other Income / (Expense), net	-0.01	-0.19	0.30	-0.46	-2.86	1.24	-0.39	-1.85	1.58	-0.03	-0.28
Income Tax Expense	0.00	0.00	0.00	-0.02	0.18	-0.38	0.11	-0.78	0.00	0.00	0.00
Preferred Stock Dividends Declared	-	-	-	-	-	-	7.63	9.63	7.24	0.01	0.00
Basic Earnings per Share	($0.05)	($0.05)	($0.49)	($0.68)	($0.25)	$0.06	($23.74)	($33.16)	($2.15)	($1.17)	($0.63)
Weighted Average Basic Shares Outstanding	125.62M	12.56M	12.78M	13.31M	13.27M	13.27M	656.93K	1.93M	11.97M	19.15M	30.29M
Diluted Earnings per Share	($0.05)	($0.05)	($0.49)	($0.68)	($0.25)	$0.06	($23.74)	($33.16)	($2.15)	($1.17)	($0.63)
Weighted Average Diluted Shares Outstanding	125.62M	12.56M	12.78M	13.31M	13.27M	13.31M	656.93K	1.93M	11.97M	19.15M	30.29M

This table shows Cosmos Health's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-3.36	-21	-1.87	-2.59	-8.38	-9.54	-0.82	-2.83	-5.35	-10	-2.81
Consolidated Net Income / (Loss)	-3.35	-14	-1.87	-2.59	-2.18	-9.54	-0.82	-2.83	-5.35	-10	-2.81
Net Income / (Loss) Continuing Operations	-3.35	-14	-1.87	-2.59	-2.18	-9.54	-0.82	-2.83	-5.35	-10	-2.81
Total Pre-Tax Income	-3.42	-14	-1.87	-2.59	-2.18	-9.54	-0.82	-2.83	-5.35	-10	-2.81
Total Operating Income	-3.02	-14	-1.84	-2.50	-2.24	-8.97	-0.83	-2.65	-1.82	-11	-2.18
Total Gross Profit	1.21	1.23	1.33	0.77	1.21	1.00	2.05	1.16	2.60	2.08	1.38
Total Revenue	13	16	15	13	12	14	14	15	17	20	18
Operating Revenue	13	16	15	13	12	14	14	15	17	20	18
Total Cost of Revenue	12	15	13	12	11	13	12	14	15	18	17
Operating Cost of Revenue	12	15	13	12	11	13	12	14	15	18	17
Total Operating Expenses	4.23	15	3.17	3.27	3.45	9.97	2.88	3.81	4.42	13	3.57
Selling, General & Admin Expense	2.57	13	1.42	1.39	1.78	7.14	1.48	1.49	2.04	11	1.80
Marketing Expense	0.16	0.26	0.17	0.11	0.04	0.03	0.03	0.02	0.06	0.04	0.02
Research & Development Expense	-	-	0.00	0.00	0.00	0.53	0.02	0.07	0.02	0.41	0.00
Depreciation Expense	0.25	0.14	0.32	0.31	0.30	0.31	0.32	0.35	0.38	0.32	0.35
Other Operating Expenses / (Income)	1.25	1.28	1.26	1.45	1.32	1.66	1.04	1.87	1.92	1.95	1.40
Total Other Income / (Expense), net	-0.40	-0.16	-0.03	-0.09	0.06	-0.57	0.02	-0.18	-3.53	1.26	-0.62
Interest Expense	0.15	0.34	0.17	0.34	0.18	0.32	0.19	0.55	0.87	0.94	0.81
Interest & Investment Income	0.11	0.11	0.11	0.10	0.10	0.10	0.09	0.11	0.10	0.09	0.04
Other Income / (Expense), net	-0.36	0.07	0.03	0.15	0.14	-0.35	0.11	0.26	-2.76	2.11	0.16
Income Tax Expense	-0.07	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Basic Earnings per Share	($0.27)	($1.75)	($0.11)	($0.15)	($0.45)	($0.50)	($0.03)	($0.10)	($0.17)	($0.33)	($0.06)
Weighted Average Basic Shares Outstanding	12.59M	11.97M	16.85M	17.83M	18.42M	19.15M	26.04M	28.75M	30.63M	30.29M	47.09M
Diluted Earnings per Share	($0.27)	($1.75)	($0.11)	($0.15)	($0.45)	($0.50)	($0.03)	($0.10)	($0.17)	($0.33)	($0.06)
Weighted Average Diluted Shares Outstanding	12.59M	11.97M	16.85M	17.83M	18.42M	19.15M	26.04M	28.75M	30.63M	30.29M	47.09M
Weighted Average Basic & Diluted Shares Outstanding	13.40M	0.00	-	17.83M	23.35M	0.00	28.75M	30.21M	34.92M	0.00	54.43M

This table details how cash moves in and out of Cosmos Health's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-0.25	0.52	0.07	0.08	-0.83	0.59	-0.34	20	-17	-3.52	3.59
Net Cash From Operating Activities	-0.50	-2.13	-8.76	-1.56	-4.79	-12	-7.10	-15	-16	-7.72	-8.45
Net Cash From Continuing Operating Activities	-0.27	0.70	3.76	-1.75	6.37	23	-7.10	-15	-16	-7.72	-8.45
Net Income / (Loss) Continuing Operations	-6.69	-0.60	-6.21	-9.06	-3.30	0.82	-7.96	-14	-19	-16	-19
Consolidated Net Income / (Loss)	-6.69	-0.60	-6.21	-9.06	-3.30	0.82	-7.96	-14	-19	-16	-19
Depreciation Expense	0.01	0.01	0.03	0.04	0.23	0.27	0.35	0.10	0.59	1.22	1.36
Amortization Expense	0.00	0.02	0.52	5.68	0.48	0.16	0.85	1.71	0.02	0.03	0.01
Non-Cash Adjustments To Reconcile Net Income	6.18	0.02	3.06	3.57	0.93	1.93	4.20	-0.65	10	7.07	9.49
Changes in Operating Assets and Liabilities, net	0.23	1.26	6.36	-1.99	8.02	19	-4.54	-2.20	-7.71	0.15	-0.16
Net Cash From Investing Activities	-0.04	-0.14	-0.01	-0.20	0.59	-0.12	-0.83	-0.02	-14	-0.80	-2.01
Net Cash From Continuing Investing Activities	-0.04	-0.14	-0.01	0.81	0.59	-0.12	-0.83	-0.02	-14	-0.80	-2.01
Purchase of Property, Plant & Equipment	0.00	-0.01	-0.06	0.50	-0.67	-0.12	-0.58	-0.07	-1.31	-0.42	-0.06
Sale and/or Maturity of Investments	-	-	-	0.00	1.26	0.00	0.06	0.35	0.81	0.47	0.14
Other Investing Activities, net	-0.04	-0.13	-	-	-	0.00	-	0.01	-1.83	-0.85	-2.10
Net Cash From Financing Activities	0.33	2.74	9.29	1.99	3.59	12	7.27	35	13	5.05	14
Net Cash From Continuing Financing Activities	0.33	2.74	9.29	13	28	12	7.27	35	13	5.05	14
Repayment of Debt	0.16	-0.25	-1.79	6.20	12	-25	-25	-23	-2.43	-27	-30
Issuance of Debt	0.17	3.02	11	6.42	17	38	33	27	21	27	39
Issuance of Common Equity	-	0.00	0.09	-0.08	-0.85	0.00	0.25	52	14	0.65	5.42
Other Financing Activities, net	0.00	-0.02	-0.05	0.00	0.07	-0.24	-0.23	-21	-20	4.21	-0.01
Cash Interest Paid	0.00	0.03	0.13	0.30	0.45	0.96	2.06	0.59	0.41	0.70	0.95
Cash Income Taxes Paid	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.00	0.00	0.00

This table details how cash moves in and out of Cosmos Health's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	0.13	1.47	-2.97	-0.52	2.97	-3.00	0.43	-0.09	3.98	-0.72	-1.43
Net Cash From Operating Activities	-4.52	0.95	-3.41	-1.21	0.74	-3.83	-0.19	-1.21	-2.46	-4.60	-1.07
Net Cash From Continuing Operating Activities	-4.43	0.95	-3.41	-1.21	0.74	-3.83	-0.19	-1.21	-2.46	-4.60	-1.07
Net Income / (Loss) Continuing Operations	-3.35	-14	-1.87	-2.59	-2.18	-9.54	-0.82	-2.83	-5.35	-10	-2.81
Consolidated Net Income / (Loss)	-3.35	-14	-1.87	-2.59	-2.18	-9.54	-0.82	-2.83	-5.35	-10	-2.81
Depreciation Expense	0.21	0.21	0.31	0.31	0.30	0.30	0.32	0.35	0.38	0.32	0.35
Amortization Expense	0.04	-0.08	0.01	0.01	0.01	0.01	0.00	-0.00	0.00	0.00	0.00
Non-Cash Adjustments To Reconcile Net Income	1.41	12	0.39	0.42	0.50	5.76	0.60	0.95	3.37	4.57	0.88
Changes in Operating Assets and Liabilities, net	-2.74	2.95	-2.25	0.65	2.12	-0.37	-0.29	0.32	-0.85	0.66	0.51
Net Cash From Investing Activities	-1.95	-3.36	0.13	0.12	-0.04	-1.01	-0.01	0.07	-1.01	-1.07	-0.71
Net Cash From Continuing Investing Activities	-1.95	-3.36	0.13	0.12	-0.04	-1.01	-0.01	0.07	-1.01	-1.07	-0.71
Purchase of Property, Plant & Equipment	-0.02	-0.05	-0.08	-0.03	-0.23	-0.07	-0.01	-0.02	-0.01	-0.01	-0.01
Divestitures	-	-	0.00	-0.00	-	-	-	-	-	-	0.40
Sale and/or Maturity of Investments	0.26	0.20	0.21	0.15	0.19	-0.08	0.01	0.19	0.00	-0.06	0.00
Other Investing Activities, net	-	-	-	-	-	-0.85	-0.00	-	-	-1.00	-1.10
Net Cash From Financing Activities	6.34	4.29	0.21	0.54	2.68	1.62	0.56	1.60	7.19	4.70	0.35
Net Cash From Continuing Financing Activities	6.34	4.29	0.21	0.54	2.68	1.62	0.56	1.60	7.19	4.70	0.35
Repayment of Debt	-15	14	-6.37	-6.53	-7.82	-5.92	-6.95	-7.65	-9.80	-6.02	-9.46
Issuance of Debt	6.01	5.97	5.93	7.10	6.25	7.54	7.51	7.83	17	6.32	7.97
Issuance of Common Equity	5.20	3.58	0.65	-	-	-	0.00	-	-	4.40	1.83
Other Financing Activities, net	10	-19	-0.01	0.62	3.60	-0.01	-0.01	1.42	-1.42	-0.00	-0.00
Cash Interest Paid	-0.50	0.09	0.23	0.28	-0.31	0.51	0.10	0.28	0.23	0.34	0.09
Cash Income Taxes Paid	-	-	-	-	-	-	0.00	-	-	-	0.00

This table presents Cosmos Health's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	0.66	3.12	11	21	24	44	49	68	66	54	65
Total Current Assets	0.55	2.64	9.51	18	21	41	40	56	37	25	38
Cash & Equivalents	0.20	0.72	0.78	0.86	0.04	0.63	0.29	21	3.83	0.32	0.72
Restricted Cash	-	-	-	-	-	-	-	-	-	0.00	2.74
Short-Term Investments	-	-	0.00	2.72	0.24	0.22	0.01	0.01	0.02	0.02	0.05
Note & Lease Receivable	-	-	-	0.00	0.17	0.27	0.38	0.80	0.85	1.17	0.49
Accounts Receivable	0.10	0.79	1.43	4.94	9.27	27	30	26	21	15	22
Inventories, net	0.19	0.46	3.09	3.20	3.47	3.29	3.15	3.45	4.79	4.36	5.78
Prepaid Expenses	0.06	0.66	4.21	6.62	7.49	8.62	6.25	4.94	6.25	4.89	6.54
Plant, Property, & Equipment, net	0.05	0.05	0.11	1.43	1.73	1.76	1.89	1.82	10	9.69	11
Total Noncurrent Assets	0.06	0.43	1.05	0.92	0.97	1.31	7.71	9.85	19	19	17
Noncurrent Note & Lease Receivables	-	-	-	-	-	0.00	4.62	7.69	7.08	5.79	3.15
Goodwill	-	0.00	0.04	0.30	0.26	0.23	0.49	0.71	7.81	7.76	7.57
Other Noncurrent Operating Assets	0.06	0.43	1.01	0.63	0.70	0.91	1.75	1.46	4.19	5.62	5.79
Total Liabilities & Shareholders' Equity	0.66	3.12	11	21	24	44	49	68	66	54	65
Total Liabilities	1.91	4.87	14	24	30	48	45	28	30	30	47
Total Current Liabilities	1.91	4.87	14	22	28	34	30	22	24	26	38
Short-Term Debt	-	0.00	0.12	14	15	1.45	1.85	8.02	8.20	9.53	14
Accounts Payable	0.73	3.62	12	6.07	9.03	12	13	10	12	12	17
Other Current Liabilities	0.08	0.17	0.01	1.63	3.11	19	13	2.99	3.81	3.58	7.35
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	0.22	0.79
Total Noncurrent Liabilities	0.00	0.00	0.00	1.74	2.10	14	15	6.63	5.65	4.02	8.78
Long-Term Debt	-	-	0.00	1.55	1.55	12	13	2.86	3.04	1.56	5.85
Other Noncurrent Operating Liabilities	-	-	0.00	0.18	0.46	1.20	2.25	3.74	2.61	2.46	2.93
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-1.25	-1.75	-3.03	-2.87	-5.64	-4.16	4.38	39	36	25	18
Total Preferred & Common Equity	-1.25	-1.75	-3.03	-3.32	-6.46	-4.16	4.38	39	36	25	18
Total Common Equity	-1.25	-1.75	-3.03	-2.87	-5.64	-4.16	4.38	39	36	25	18
Common Stock	0.26	0.30	5.67	13	14	14	40	107	129	142	152
Retained Earnings	-0.40	-1.00	-7.21	-16	-20	-19	-34	-66	-92	-114	-133
Accumulated Other Comprehensive Income / (Loss)	-1.11	-1.05	-1.39	0.03	-0.02	0.85	-0.15	-1.13	-0.42	-2.13	0.33
Other Equity Adjustments	-	-	-	-	-	-	-	-	-	-0.00	-0.92

This table presents Cosmos Health's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	72	62	61	65	57	62	69	62
Total Current Assets	46	34	33	36	28	31	38	37
Cash & Equivalents	2.36	0.87	0.34	3.31	0.74	0.66	0.89	0.51
Restricted Cash	-	-	-	-	-	-	3.74	1.64
Short-Term Investments	0.02	0.02	0.02	0.02	0.03	0.03	0.03	0.03
Note & Lease Receivable	0.81	0.84	0.87	0.94	1.44	1.43	1.83	0.49
Accounts Receivable	29	20	20	19	16	17	20	21
Inventories, net	5.96	4.87	4.32	4.89	4.74	5.11	5.68	5.65
Prepaid Expenses	8.74	7.20	7.86	8.31	5.23	6.43	6.28	8.01
Plant, Property, & Equipment, net	10	10	10	11	10	11	11	10
Total Noncurrent Assets	15	18	17	18	19	20	21	15
Noncurrent Note & Lease Receivables	7.33	6.70	6.43	6.48	5.81	6.26	5.84	3.12
Goodwill	4.07	7.96	7.72	7.75	7.80	8.23	7.96	7.23
Other Noncurrent Operating Assets	3.40	3.22	3.21	3.48	5.72	5.96	6.93	4.85
Total Liabilities & Shareholders' Equity	72	62	61	65	57	62	69	62
Total Liabilities	27	28	29	30	31	36	46	43
Total Current Liabilities	23	24	25	25	27	31	39	34
Short-Term Debt	6.41	7.88	8.65	7.61	10	13	15	11
Accounts Payable	13	12	12	13	12	13	15	15
Other Current Liabilities	2.92	3.95	4.26	4.78	3.97	4.49	8.65	7.77
Other Current Nonoperating Liabilities	-	0.10	-	-	0.26	0.35	0.52	0.87
Total Noncurrent Liabilities	4.37	4.24	3.89	4.33	4.65	4.44	7.82	8.47
Long-Term Debt	3.16	2.70	2.39	2.65	2.09	2.05	5.71	6.12
Other Noncurrent Operating Liabilities	0.95	1.53	1.49	1.68	2.56	2.38	2.11	2.34
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	44	35	32	35	26	26	23	20
Total Preferred & Common Equity	44	35	32	35	26	26	23	20
Total Common Equity	44	35	32	35	26	26	23	20
Common Stock	118	130	130	141	143	144	146	157
Retained Earnings	-71	-94	-96	-104	-115	-118	-123	-136
Accumulated Other Comprehensive Income / (Loss)	-1.60	-1.02	-1.20	-0.45	-1.10	0.46	0.71	0.04
Other Equity Adjustments	-	-	-	-	-	-	-	-0.92

This table displays calculated financial ratios and metrics derived from Cosmos Health's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	125,630,532.00	125,630,532.00	126,867,038.00	13,321,705.00	13,087,478.00	12,840,059.00	17,039,208.00	83,797,481.00	13,404,204.00	23,346,049.00	34,919,920.00
DEI Adjusted Shares Outstanding	5,025,221.00	5,025,221.00	5,074,682.00	532,868.00	523,499.00	513,602.00	681,568.00	3,351,899.00	13,404,204.00	23,346,049.00	34,919,920.00
DEI Earnings Per Adjusted Shares Outstanding	-1.33	-0.12	-1.22	16.99	-6.30	1.60	-22.88	-19.08	-1.92	-0.96	-0.55
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-93.01%	1,165.53%	344.28%	23.56%	6.99%	39.65%	1.50%	-10.48%	6.02%	1.97%	19.93%
EBITDA Growth	-106.21%	16.67%	-991.66%	200.29%	-159.49%	282.78%	-184.60%	-102.47%	-161.25%	27.05%	-9.00%
EBIT Growth	-106.29%	11.98%	-1,059.11%	63.04%	-84.51%	227.00%	-224.32%	-89.57%	-117.17%	23.09%	-9.05%
NOPAT Growth	-105.07%	54.23%	-2,306.00%	74.79%	79.18%	2,093.36%	-188.90%	-64.87%	-192.09%	28.80%	-7.45%
Net Income Growth	-210.64%	91.01%	-933.24%	-45.91%	63.59%	124.88%	-1,070.00%	-73.71%	-34.07%	12.73%	-18.30%
EPS Growth	-200.00%	0.00%	-880.00%	-38.78%	63.24%	124.88%	-1,070.00%	-39.68%	93.52%	45.58%	46.15%
Operating Cash Flow Growth	-107.62%	-327.71%	-312.03%	82.25%	-207.90%	-140.18%	38.29%	-109.53%	-5.15%	50.65%	-9.47%
Free Cash Flow Firm Growth	1,779.37%	-85.69%	-348.46%	-480.24%	85.92%	345.14%	-396.62%	-24.73%	-78.10%	89.74%	-279.01%
Invested Capital Growth	-128.76%	-70.79%	-49.39%	321.29%	19.73%	-8.37%	109.89%	58.53%	45.74%	-18.23%	-1.27%
Revenue Q/Q Growth	443.96%	67.19%	30.36%	-6.28%	11.34%	8.86%	-0.22%	-7.58%	7.63%	-2.88%	9.16%
EBITDA Q/Q Growth	10.98%	-9.13%	-55.31%	56.39%	-54.78%	82.07%	-86.59%	-729.68%	-43.88%	23.41%	0.20%
EBIT Q/Q Growth	12.78%	-12.92%	-68.67%	-135.23%	39.44%	88.78%	-69.08%	-288.07%	-36.57%	21.25%	0.16%
NOPAT Q/Q Growth	13.84%	39.03%	-73.48%	46.45%	86.23%	39.02%	-25.94%	-987.12%	-40.46%	22.91%	-17.10%
Net Income Q/Q Growth	-1,035.65%	90.93%	-82.92%	-311.04%	75.35%	-52.92%	-8.76%	-208.52%	-18.78%	20.64%	-3.25%
EPS Q/Q Growth	0.00%	0.00%	-63.33%	-277.78%	75.00%	-52.92%	-8.76%	-0.30%	38.04%	36.41%	-3.28%
Operating Cash Flow Q/Q Growth	17.46%	-51.59%	-32.12%	68.78%	-51.24%	0.49%	-5.79%	-143.77%	41.89%	-163.25%	-9.92%
Free Cash Flow Firm Q/Q Growth	12,101.04%	-87.67%	-7,145.60%	-615.41%	30.27%	121.72%	-110.60%	-647.78%	22.84%	25.68%	-50.41%
Invested Capital Q/Q Growth	-127.80%	-13.10%	10.44%	306.77%	464.52%	-55.41%	-20.83%	17.17%	-16.52%	-15.24%	-10.98%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	9.18%	8.90%	6.52%	6.50%	9.23%	14.55%	14.81%	11.83%	8.15%	7.92%	12.10%
EBITDA Margin	-82.89%	-5.46%	-13.41%	10.89%	-6.05%	7.92%	-6.60%	-14.93%	-36.80%	-26.33%	-23.93%
Operating Margin	-82.89%	-3.00%	-16.23%	-3.31%	-0.64%	4.90%	-8.06%	-14.84%	-40.90%	-28.56%	-25.59%
EBIT Margin	-83.90%	-5.84%	-15.22%	-4.55%	-7.85%	7.14%	-8.75%	-18.52%	-37.95%	-28.62%	-26.03%
Profit (Net Income) Margin	-1,252.88%	-8.90%	-20.69%	-24.43%	-8.31%	1.48%	-14.16%	-27.47%	-34.74%	-29.73%	-29.33%
Tax Burden Percent	100.00%	100.13%	100.05%	100.19%	105.87%	68.49%	101.45%	105.94%	100.00%	100.00%	100.00%
Interest Burden Percent	1,493.18%	152.26%	135.84%	535.46%	100.00%	30.28%	159.51%	139.98%	91.55%	103.89%	112.70%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	-31.51%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-17.30%	0.00%	0.00%	-38.43%	-2.00%	38.11%	-22.87%	-21.53%	-41.74%	-27.57%	-33.13%
ROIC Less NNEP Spread (ROIC-NNEP)	1,961.50%	0.00%	0.00%	-196.62%	-25.59%	18.84%	-57.65%	-370.06%	269.47%	-85.28%	-87.09%
Return on Net Nonoperating Assets (RNNOA)	-299.23%	0.00%	0.00%	345.87%	79.59%	-54.87%	-7,266.35%	-41.82%	-7.50%	-25.86%	-56.00%
Return on Equity (ROE)	-316.53%	40.06%	259.79%	307.44%	77.59%	-16.75%	-7,289.22%	-63.35%	-49.23%	-53.43%	-89.13%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	-155.72%	-19.96%	46.85%	-93.79%	-66.81%	-78.96%	-7.51%	-31.85%
Operating Return on Assets (OROA)	-11.35%	-20.88%	-66.25%	-10.77%	-13.98%	11.69%	-10.55%	-15.88%	-30.22%	-25.89%	-28.36%
Return on Assets (ROA)	-169.48%	-31.83%	-90.03%	-57.77%	-14.80%	2.42%	-17.07%	-23.55%	-27.66%	-26.90%	-31.96%
Return on Common Equity (ROCE)	-316.53%	40.06%	259.79%	307.44%	77.59%	-16.75%	-7,289.22%	-63.35%	-49.23%	-53.43%	-89.13%
Return on Equity Simple (ROE_SIMPLE)	535.98%	34.29%	205.09%	273.12%	51.06%	-19.73%	-181.80%	-35.21%	-51.45%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-0.31	-0.14	-3.41	-0.86	-0.18	3.57	-3.17	-5.23	-15	-11	-12
NOPAT Margin	-58.02%	-2.10%	-11.36%	-2.32%	-0.45%	6.44%	-5.64%	-10.39%	-28.63%	-19.99%	-17.91%
Net Nonoperating Expense Percent (NNEP)	-1,978.80%	-100.42%	-406.31%	158.18%	23.60%	19.27%	34.78%	348.53%	-311.20%	57.72%	53.96%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-32.32%	-30.54%	-30.95%
Cost of Revenue to Revenue	90.82%	91.10%	93.48%	93.50%	90.77%	85.45%	85.19%	88.17%	91.85%	92.08%	87.90%
SG&A Expenses to Revenue	91.05%	11.76%	16.17%	9.69%	8.29%	3.80%	16.37%	20.23%	36.80%	21.56%	23.93%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.31%	0.98%	0.80%
Operating Expenses to Revenue	92.07%	11.89%	22.75%	9.81%	9.88%	9.65%	22.87%	26.68%	49.05%	36.48%	37.69%
Earnings before Interest and Taxes (EBIT)	-0.45	-0.39	-4.57	-1.69	-3.12	3.96	-4.92	-9.33	-20	-16	-17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-0.44	-0.37	-4.03	4.04	-2.40	4.39	-3.71	-7.52	-20	-14	-16
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	7.55	0.08	0.52	0.64	0.94
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	8.49	0.08	0.67	0.93	1.60
Price to Revenue (P/Rev)	258.89	20.46	4.65	1.85	0.73	0.45	0.59	0.06	0.35	0.29	0.27
Price to Earnings (P/E)	0.00	0.00	0.00	7.58	0.00	30.35	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	13.20%	0.00%	3.30%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	9.81	4.61	4.25	2.53	0.00	0.61	0.74	0.95
Enterprise Value to Revenue (EV/Rev)	258.51	20.35	4.63	2.16	1.13	0.69	0.84	0.00	0.49	0.48	0.51
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	19.84	0.00	8.66	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	9.61	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	10.65	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	22.39	155.91	0.00	0.00	0.00	8.67	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	-0.04	-5.25	-2.93	-3.36	3.36	0.28	0.31	0.45	1.05
Long-Term Debt to Equity	0.00	0.00	0.00	-0.54	-0.29	-3.01	2.94	0.07	0.08	0.06	0.32
Financial Leverage	-0.15	0.30	0.29	-1.76	-3.11	-2.91	126.05	0.11	-0.03	0.30	0.64
Leverage Ratio	1.87	-1.26	-2.89	-5.32	-5.24	-6.91	426.98	2.69	1.78	1.99	2.79
Compound Leverage Factor	27.89	-1.92	-3.92	-28.50	-5.24	-2.09	681.09	3.77	1.63	2.06	3.14
Debt to Total Capital	0.00%	0.00%	-4.18%	123.50%	151.83%	142.43%	77.07%	21.73%	23.77%	31.15%	51.24%
Short-Term Debt to Total Capital	0.00%	0.00%	-4.18%	110.76%	136.78%	14.82%	9.66%	15.97%	17.34%	26.76%	35.75%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	12.75%	15.05%	127.61%	67.40%	5.76%	6.43%	4.39%	15.49%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.74%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	104.18%	-23.50%	-51.83%	-42.43%	22.93%	78.27%	76.23%	68.85%	48.76%
Debt to EBITDA	0.00	0.00	-0.03	3.73	-6.88	3.18	-3.96	-1.45	-0.57	-0.77	-1.24
Net Debt to EBITDA	0.00	0.00	0.16	2.84	-6.76	2.99	-3.88	1.31	-0.38	-0.75	-1.02
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.39	-0.68	2.85	-3.47	-0.38	-0.15	-0.11	-0.37
Debt to NOPAT	0.00	0.00	-0.04	-17.52	-92.22	3.91	-4.64	-2.08	-0.74	-1.02	-1.66
Net Debt to NOPAT	0.00	0.00	0.19	-13.35	-90.67	3.67	-4.54	1.88	-0.48	-0.99	-1.36
Long-Term Debt to NOPAT	0.00	0.00	0.00	-1.81	-9.14	3.51	-4.06	-0.55	-0.20	-0.14	-0.50
Altman Z-Score	38.75	17.46	6.09	1.91	0.30	1.45	0.52	-0.40	-1.55	-2.58	-2.48
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.29	0.54	0.69	0.82	0.75	1.19	1.33	2.59	1.51	0.99	1.00
Quick Ratio	0.15	0.31	0.16	0.38	0.34	0.82	1.02	2.21	1.05	0.63	0.61
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	6.16	0.88	-2.19	-13	-1.79	4.39	-13	-16	-29	-2.97	-11
Operating Cash Flow to CapEx	0.00%	-16,589.27%	-15,830.53%	0.00%	-711.79%	-9,768.41%	-1,220.71%	-20,039.40%	-1,190.68%	-1,845.85%	-15,173.08%
Free Cash Flow to Firm to Interest Expense	69.00	4.28	-1.34	0.00	0.00	1.61	-4.38	-4.09	0.00	-2.93	-4.40
Operating Cash Flow to Interest Expense	-5.57	-10.32	-5.35	0.00	0.00	-4.22	-2.39	-3.75	0.00	-7.62	-3.31
Operating Cash Flow Less CapEx to Interest Expense	-5.57	-10.38	-5.38	0.00	0.00	-4.26	-2.58	-3.77	0.00	-8.04	-3.33
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.14	3.58	4.35	2.36	1.78	1.64	1.21	0.86	0.80	0.90	1.09
Accounts Receivable Turnover	0.00	15.18	27.03	11.64	5.58	3.06	1.98	1.79	2.26	3.06	3.55
Inventory Turnover	0.00	18.76	15.77	11.01	10.79	13.99	14.88	13.45	11.90	10.96	11.32
Fixed Asset Turnover	17.08	130.86	358.84	48.15	25.11	31.73	30.86	27.18	8.79	5.44	6.44
Accounts Payable Turnover	0.70	2.83	3.54	3.79	4.77	4.51	3.88	3.85	4.36	4.08	3.95
Days Sales Outstanding (DSO)	0.00	24.05	13.50	31.35	65.37	119.16	183.89	203.57	161.59	119.26	102.84
Days Inventory Outstanding (DIO)	0.00	19.46	23.14	33.14	33.84	26.08	24.53	27.13	30.68	33.30	32.23
Days Payable Outstanding (DPO)	524.52	129.12	103.04	96.26	76.52	80.96	94.10	94.83	83.69	89.48	92.41
Cash Conversion Cycle (CCC)	-524.52	-85.62	-66.39	-31.77	22.68	64.28	114.33	135.88	108.57	63.09	42.66
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-1.45	-2.47	-3.69	8.16	9.77	8.96	19	30	43	36	35
Invested Capital Turnover	0.30	-3.45	-9.75	16.58	4.42	5.92	4.05	2.07	1.46	1.38	1.85
Increase / (Decrease) in Invested Capital	-6.47	-1.02	-1.22	12	1.61	-0.82	9.84	11	14	-7.92	-0.45
Enterprise Value (EV)	138	137	139	80	45	38	47	-6.28	26	26	33
Market Capitalization	138	138	140	69	29	25	33	3.20	19	16	17
Book Value per Share	($0.01)	($0.01)	($0.02)	($0.22)	($0.43)	($0.32)	$0.26	$2.24	$2.69	$1.05	$0.53
Tangible Book Value per Share	($0.01)	($0.01)	($0.02)	($0.24)	($0.45)	($0.34)	$0.23	$2.20	$2.11	$0.72	$0.31
Total Capital	-1.25	-1.75	-2.91	12	11	9.81	19	50	47	36	38
Total Debt	0.00	0.00	0.12	15	17	14	15	11	11	11	19
Total Long-Term Debt	0.00	0.00	0.00	1.55	1.64	13	13	2.89	3.04	1.56	5.85
Net Debt	-0.20	-0.72	-0.66	11	16	13	14	-9.86	7.39	11	16
Capital Expenditures (CapEx)	0.00	0.01	0.06	-0.50	0.67	0.12	0.58	0.07	1.31	0.42	0.06
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1.56	-2.95	-4.85	6.00	7.54	7.09	11	22	17	8.90	10
Debt-free Net Working Capital (DFNWC)	-1.36	-2.23	-4.07	9.58	7.81	7.94	12	43	20	9.24	14
Net Working Capital (NWC)	-1.36	-2.23	-4.19	-3.93	-7.06	6.48	9.90	35	12	-0.30	0.12
Net Nonoperating Expense (NNE)	6.38	0.46	2.80	8.20	3.12	2.75	4.79	8.60	3.26	5.30	7.45
Net Nonoperating Obligations (NNO)	-0.20	-0.72	-0.66	11	15	13	14	-9.48	7.39	11	17
Total Depreciation and Amortization (D&A)	0.01	0.03	0.54	5.73	0.71	0.43	1.21	1.81	0.61	1.25	1.37
Debt-free, Cash-free Net Working Capital to Revenue	-291.55%	-43.69%	-16.17%	16.18%	18.99%	12.79%	20.36%	43.44%	31.16%	16.35%	15.50%
Debt-free Net Working Capital to Revenue	-254.45%	-33.08%	-13.57%	25.84%	19.69%	14.32%	20.89%	84.68%	38.38%	16.97%	20.87%
Net Working Capital to Revenue	-254.45%	-33.08%	-13.97%	-10.59%	-17.80%	11.70%	17.61%	68.76%	23.02%	-0.54%	0.18%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.25)	$0.00	($12.25)	($17.00)	($6.25)	$1.50	$0.00	($33.16)	($2.15)	($1.17)	($0.63)
Adjusted Weighted Average Basic Shares Outstanding	5.02M	5.03M	511.20K	532.26K	530.94K	530.80K	0.00	1.93M	11.97M	19.15M	30.29M
Adjusted Diluted Earnings per Share	($1.25)	$0.00	($12.25)	($17.00)	($6.25)	$1.50	$0.00	($33.16)	($2.15)	($1.17)	($0.63)
Adjusted Weighted Average Diluted Shares Outstanding	5.02M	5.03M	511.20K	532.26K	530.94K	532.31K	0.00	1.93M	11.97M	19.15M	30.29M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	($12.25)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	502.59K	511.20K	995.21K	530.94K	0.00	0.00	0.00	0.00	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-0.31	-0.14	-2.05	-0.86	-0.18	1.90	-3.17	-5.23	-15	-11	-12
Normalized NOPAT Margin	-58.02%	-2.10%	-6.82%	-2.32%	-0.45%	3.43%	-5.64%	-10.39%	-28.63%	-19.62%	-17.74%
Pre Tax Income Margin	-1,252.84%	-8.89%	-20.68%	-24.39%	-7.85%	2.16%	-13.95%	-25.93%	-34.74%	-29.73%	-29.33%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-5.01	-1.91	-2.79	0.00	0.00	1.45	-1.65	-2.35	0.00	-15.39	-6.65
NOPAT to Interest Expense	-3.47	-0.69	-2.08	0.00	0.00	1.31	-1.07	-1.32	0.00	-10.75	-4.58
EBIT Less CapEx to Interest Expense	-5.01	-1.98	-2.82	0.00	0.00	1.41	-1.85	-2.37	0.00	-15.80	-6.67
NOPAT Less CapEx to Interest Expense	-3.47	-0.75	-2.12	0.00	0.00	1.27	-1.26	-1.34	0.00	-11.16	-4.60
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	24.37%	-4.73%	0.00%	-0.54%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Cosmos Health's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	10,620,670.00	13,404,204.00	13,404,204.00	13,404,204.00	35,668,046.00	23,346,049.00	23,346,049.00	28,751,422.00	30,213,876.00	34,919,920.00	34,919,920.00
DEI Adjusted Shares Outstanding	10,620,670.00	13,404,204.00	13,404,204.00	13,404,204.00	35,668,046.00	23,346,049.00	23,346,049.00	28,751,422.00	30,213,876.00	34,919,920.00	34,919,920.00
DEI Earnings Per Adjusted Shares Outstanding	-0.32	-1.57	-0.14	-0.19	-0.23	-0.41	-0.04	-0.10	-0.18	-0.29	-0.08
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.72%	31.41%	18.06%	6.82%	-3.22%	-10.18%	-5.98%	11.65%	37.86%	38.52%	30.74%
EBITDA Growth	-665.69%	-80.99%	36.69%	-160.22%	42.47%	32.71%	72.95%	0.34%	-133.85%	0.32%	-317.81%
EBIT Growth	-313.02%	-66.98%	26.29%	-158.19%	37.69%	31.08%	59.99%	-1.44%	-117.99%	0.26%	-180.66%
NOPAT Growth	-776.84%	-86.17%	30.74%	2.89%	25.77%	34.00%	54.62%	-5.73%	18.80%	-27.21%	-162.16%
Net Income Growth	-69.77%	-27.10%	-305.92%	-163.95%	34.83%	30.61%	56.17%	-9.16%	-145.26%	-6.32%	-242.92%
EPS Growth	86.01%	91.33%	-175.00%	-66.67%	-66.67%	71.43%	72.73%	33.33%	62.22%	34.00%	-100.00%
Operating Cash Flow Growth	-195.93%	109.22%	46.22%	78.83%	116.35%	-502.83%	94.54%	0.08%	-431.86%	-19.89%	-472.72%
Free Cash Flow Firm Growth	-1,386.86%	-43.64%	71.14%	118.40%	129.81%	107.08%	228.56%	-97.91%	-85.52%	-559.60%	-86.62%
Invested Capital Growth	104.56%	45.74%	8.60%	-13.25%	-19.46%	-18.23%	-15.22%	-4.56%	-5.99%	-1.27%	-6.26%
Revenue Q/Q Growth	3.72%	23.49%	-7.91%	-9.45%	-6.02%	14.61%	-3.60%	7.53%	16.04%	15.15%	-9.01%
EBITDA Q/Q Growth	-299.16%	-328.25%	88.90%	-37.14%	11.75%	-400.86%	95.54%	-401.39%	-107.07%	-113.49%	81.30%
EBIT Q/Q Growth	-270.60%	-300.73%	86.65%	-30.19%	10.56%	-343.25%	92.25%	-228.70%	-92.19%	-102.80%	78.19%
NOPAT Q/Q Growth	-17.11%	-350.28%	86.49%	-36.27%	10.48%	-300.33%	90.71%	-217.51%	31.25%	-527.17%	80.85%
Net Income Q/Q Growth	-241.22%	-310.61%	86.43%	-38.79%	15.76%	-337.25%	91.43%	-245.69%	-89.28%	-89.54%	72.35%
EPS Q/Q Growth	-200.00%	-548.15%	93.71%	-36.36%	-200.00%	-11.11%	94.00%	-233.33%	-70.00%	-94.12%	81.82%
Operating Cash Flow Q/Q Growth	20.91%	121.04%	-458.52%	64.51%	161.09%	-618.24%	95.14%	-549.39%	-102.91%	-87.22%	76.78%
Free Cash Flow Firm Q/Q Growth	-10.33%	19.38%	79.27%	199.79%	78.77%	-80.85%	276.27%	-98.38%	1,139.17%	-708.08%	110.95%
Invested Capital Q/Q Growth	5.45%	-16.52%	2.11%	-3.49%	-2.10%	-15.24%	5.86%	8.65%	-3.57%	-10.98%	0.51%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	9.47%	7.77%	9.14%	5.81%	9.72%	7.06%	14.95%	7.89%	15.21%	10.55%	7.70%
EBITDA Margin	-24.37%	-84.52%	-10.19%	-15.43%	-14.49%	-63.32%	-2.93%	-13.77%	-24.58%	-45.56%	-9.37%
Operating Margin	-23.53%	-85.79%	-12.59%	-18.95%	-18.05%	-63.04%	-6.08%	-17.94%	-10.63%	-57.89%	-12.18%
EBIT Margin	-26.31%	-85.38%	-12.38%	-17.80%	-16.94%	-65.51%	-5.27%	-16.17%	-26.78%	-47.17%	-11.31%
Profit (Net Income) Margin	-26.12%	-86.84%	-12.80%	-19.62%	-17.59%	-67.09%	-5.97%	-19.18%	-31.28%	-51.49%	-15.65%
Tax Burden Percent	98.07%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	101.22%	101.71%	103.39%	110.21%	103.81%	102.41%	113.26%	118.60%	116.80%	109.16%	138.38%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-21.09%	-87.54%	-11.51%	-16.25%	-15.07%	-60.84%	-5.56%	-16.54%	-10.95%	-74.95%	-16.27%
ROIC Less NNEP Spread (ROIC-NNEP)	-29.89%	317.27%	-29.04%	-26.52%	-23.40%	-96.40%	-7.75%	-24.26%	-46.14%	-90.60%	-25.70%
Return on Net Nonoperating Assets (RNNOA)	-17.02%	-8.83%	-2.45%	-5.72%	-4.36%	-29.24%	-2.75%	-10.52%	-18.41%	-58.26%	-15.20%
Return on Equity (ROE)	-38.11%	-96.37%	-13.96%	-21.97%	-19.44%	-90.08%	-8.31%	-27.06%	-29.35%	-133.21%	-31.47%
Cash Return on Invested Capital (CROIC)	-96.76%	-78.96%	-42.78%	-17.63%	-8.50%	-7.51%	-8.37%	-19.91%	-18.39%	-31.85%	-28.24%
Operating Return on Assets (OROA)	-22.28%	-67.99%	-10.56%	-15.53%	-13.96%	-59.27%	-4.72%	-14.53%	-23.90%	-51.41%	-13.14%
Return on Assets (ROA)	-22.11%	-69.15%	-10.92%	-17.11%	-14.49%	-60.69%	-5.35%	-17.23%	-27.92%	-56.12%	-18.19%
Return on Common Equity (ROCE)	-36.79%	-96.37%	-13.96%	-21.97%	-19.44%	-90.08%	-8.31%	-27.06%	-29.35%	-133.21%	-31.47%
Return on Equity Simple (ROE_SIMPLE)	-35.32%	0.00%	-57.75%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-2.11	-9.51	-1.29	-1.75	-1.57	-6.28	-0.58	-1.85	-1.27	-7.98	-1.53
NOPAT Margin	-16.47%	-60.05%	-8.81%	-13.26%	-12.63%	-44.13%	-4.25%	-12.56%	-7.44%	-40.52%	-8.53%
Net Nonoperating Expense Percent (NNEP)	8.80%	-404.82%	17.54%	10.27%	8.33%	35.56%	2.19%	7.72%	35.20%	15.65%	9.43%
Return On Investment Capital (ROIC_SIMPLE)	-	-20.11%	-2.85%	-4.06%	-3.47%	-17.62%	-1.53%	-4.50%	-2.92%	-21.13%	-4.18%
Cost of Revenue to Revenue	90.53%	92.25%	90.86%	94.19%	90.28%	92.94%	85.05%	92.11%	84.79%	89.45%	92.30%
SG&A Expenses to Revenue	20.07%	81.96%	9.72%	10.53%	14.37%	50.21%	10.78%	10.11%	11.92%	53.85%	10.04%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	3.75%	0.11%	0.51%	0.11%	2.08%	0.00%
Operating Expenses to Revenue	33.00%	93.56%	21.73%	24.75%	27.77%	70.09%	21.02%	25.83%	25.84%	68.44%	19.89%
Earnings before Interest and Taxes (EBIT)	-3.37	-14	-1.81	-2.35	-2.10	-9.32	-0.72	-2.38	-4.58	-9.29	-2.03
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-3.13	-13	-1.49	-2.04	-1.80	-9.01	-0.40	-2.03	-4.21	-8.98	-1.68
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.38	0.52	0.28	0.43	0.45	0.64	0.39	0.46	1.45	0.94	0.56
Price to Tangible Book Value (P/TBV)	0.42	0.67	0.36	0.57	0.57	0.93	0.56	0.67	2.21	1.60	0.88
Price to Revenue (P/Rev)	0.34	0.35	0.17	0.25	0.28	0.29	0.19	0.22	0.56	0.27	0.16
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.47	0.61	0.43	0.58	0.54	0.74	0.57	0.65	1.25	0.95	0.73
Enterprise Value to Revenue (EV/Rev)	0.49	0.49	0.35	0.44	0.40	0.48	0.40	0.48	0.82	0.51	0.37
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.22	0.31	0.31	0.34	0.29	0.45	0.47	0.57	0.88	1.05	0.84
Long-Term Debt to Equity	0.08	0.08	0.08	0.07	0.08	0.06	0.08	0.08	0.25	0.32	0.31
Financial Leverage	0.57	-0.03	0.08	0.22	0.19	0.30	0.35	0.43	0.40	0.64	0.59
Leverage Ratio	2.37	1.78	1.66	1.71	1.72	1.99	1.98	2.10	2.31	2.79	2.61
Compound Leverage Factor	2.40	1.81	1.72	1.88	1.78	2.03	2.24	2.49	2.69	3.04	3.61
Debt to Total Capital	18.21%	23.77%	23.46%	25.59%	22.69%	31.15%	31.91%	36.31%	46.86%	51.24%	45.78%
Short-Term Debt to Total Capital	11.87%	17.34%	17.45%	20.03%	16.83%	26.76%	26.42%	31.33%	33.74%	35.75%	29.03%
Long-Term Debt to Total Capital	6.33%	6.43%	6.01%	5.56%	5.86%	4.39%	5.48%	4.99%	13.12%	15.49%	16.75%
Preferred Equity to Total Capital	0.69%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	81.79%	76.23%	76.54%	74.41%	77.31%	68.85%	68.09%	63.69%	53.14%	48.76%	54.22%
Debt to EBITDA	-0.72	-0.57	-0.56	-0.55	-0.55	-0.77	-0.92	-1.13	-1.30	-1.24	-0.99
Net Debt to EBITDA	-0.55	-0.38	-0.52	-0.53	-0.37	-0.75	-0.86	-1.08	-1.01	-1.02	-0.86
Long-Term Debt to EBITDA	-0.25	-0.15	-0.14	-0.12	-0.14	-0.11	-0.16	-0.16	-0.37	-0.37	-0.36
Debt to NOPAT	-0.90	-0.74	-0.72	-0.75	-0.73	-1.02	-1.19	-1.46	-2.04	-1.66	-1.32
Net Debt to NOPAT	-0.69	-0.48	-0.66	-0.73	-0.49	-0.99	-1.12	-1.39	-1.58	-1.36	-1.15
Long-Term Debt to NOPAT	-0.31	-0.20	-0.18	-0.16	-0.19	-0.14	-0.21	-0.20	-0.57	-0.50	-0.48
Altman Z-Score	-0.08	-1.21	-0.89	-0.95	-0.98	-2.20	-1.69	-1.71	-1.41	-2.10	-1.84
Noncontrolling Interest Sharing Ratio	3.47%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.06	1.51	1.46	1.35	1.44	0.99	1.05	0.98	0.99	1.00	1.08
Quick Ratio	1.41	1.05	0.94	0.86	0.91	0.63	0.67	0.61	0.58	0.61	0.63
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-29	-23	-4.80	4.79	8.56	1.64	6.17	0.10	1.24	-7.53	0.83
Operating Cash Flow to CapEx	-27,321.73%	2,037.74%	-4,127.78%	-3,544.33%	323.37%	-5,289.34%	-1,486.96%	-5,369.31%	-19,306.68%	-58,218.38%	-9,361.05%
Free Cash Flow to Firm to Interest Expense	-190.65	-68.63	-28.44	13.98	47.16	5.13	32.96	0.18	1.42	-7.98	1.01
Operating Cash Flow to Interest Expense	-30.04	2.82	-20.23	-3.54	4.08	-11.99	-1.00	-2.19	-2.82	-4.87	-1.31
Operating Cash Flow Less CapEx to Interest Expense	-30.15	2.68	-20.72	-3.64	2.82	-12.22	-1.06	-2.23	-2.83	-4.88	-1.33
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.85	0.80	0.85	0.87	0.82	0.90	0.90	0.90	0.89	1.09	1.16
Accounts Receivable Turnover	1.78	2.26	2.43	2.45	2.37	3.06	2.96	2.99	3.11	3.55	3.84
Inventory Turnover	9.26	11.90	11.10	11.38	9.50	10.96	10.10	10.53	10.02	11.32	11.99
Fixed Asset Turnover	8.48	8.79	9.27	5.44	5.38	5.44	5.31	5.28	5.63	6.44	6.85
Accounts Payable Turnover	3.76	4.36	4.37	4.43	4.06	4.08	4.06	3.95	3.88	3.95	4.59
Days Sales Outstanding (DSO)	205.53	161.59	150.33	148.92	154.27	119.26	123.23	122.26	117.23	102.84	95.14
Days Inventory Outstanding (DIO)	39.42	30.68	32.89	32.08	38.43	33.30	36.13	34.67	36.41	32.23	30.45
Days Payable Outstanding (DPO)	97.03	83.69	83.61	82.46	89.92	89.48	89.94	92.52	94.09	92.41	79.45
Cash Conversion Cycle (CCC)	147.93	108.57	99.61	98.53	102.78	63.09	69.42	64.41	59.55	42.66	46.14
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	52	43	44	43	42	36	38	41	39	35	35
Invested Capital Turnover	1.28	1.46	1.31	1.23	1.19	1.38	1.31	1.32	1.47	1.85	1.91
Increase / (Decrease) in Invested Capital	27	14	3.51	-6.54	-10	-7.92	-6.75	-1.95	-2.51	-0.45	-2.35
Enterprise Value (EV)	25	26	19	25	23	26	22	26	49	33	26
Market Capitalization	17	19	9.52	14	16	16	10	12	34	17	11
Book Value per Share	$4.16	$2.69	$2.58	$2.40	$1.96	$1.05	$1.11	$0.91	$0.77	$0.53	$0.57
Tangible Book Value per Share	$3.78	$2.11	$1.98	$1.82	$1.53	$0.72	$0.78	$0.63	$0.50	$0.31	$0.36
Total Capital	54	47	45	43	45	36	38	41	44	38	37
Total Debt	9.84	11	11	11	10	11	12	15	20	19	17
Total Long-Term Debt	3.42	3.04	2.71	2.40	2.65	1.56	2.09	2.05	5.71	5.85	6.12
Net Debt	7.46	7.39	9.70	11	6.93	11	11	14	16	16	15
Capital Expenditures (CapEx)	0.02	0.05	0.08	0.03	0.23	0.07	0.01	0.02	0.01	0.01	0.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)	28	17	18	17	15	8.90	11	12	9.59	10	11
Debt-free Net Working Capital (DFNWC)	30	20	19	17	19	9.24	11	12	14	14	13
Net Working Capital (NWC)	24	12	11	8.59	11	-0.30	1.26	-0.60	-0.43	0.12	2.81
Net Nonoperating Expense (NNE)	1.24	4.24	0.58	0.84	0.61	3.27	0.23	0.98	4.08	2.16	1.28
Net Nonoperating Obligations (NNO)	7.83	7.39	9.80	11	6.93	11	12	15	16	17	15
Total Depreciation and Amortization (D&A)	0.25	0.14	0.32	0.31	0.30	0.31	0.32	0.35	0.38	0.32	0.35
Debt-free, Cash-free Net Working Capital to Revenue	56.34%	31.16%	31.87%	29.89%	27.31%	16.35%	19.72%	21.08%	16.04%	15.50%	16.17%
Debt-free Net Working Capital to Revenue	61.13%	38.38%	33.46%	30.54%	33.26%	16.97%	21.15%	22.32%	23.85%	20.87%	19.32%
Net Working Capital to Revenue	48.20%	23.02%	19.30%	15.22%	19.68%	-0.54%	2.35%	-1.10%	-0.72%	0.18%	4.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.27)	($1.75)	($0.11)	($0.15)	($0.45)	($0.50)	($0.03)	($0.10)	($0.17)	($0.33)	($0.06)
Adjusted Weighted Average Basic Shares Outstanding	12.59M	11.97M	16.85M	17.83M	18.42M	19.15M	26.04M	28.75M	30.63M	30.29M	47.09M
Adjusted Diluted Earnings per Share	($0.27)	($1.75)	($0.11)	($0.15)	($0.45)	($0.50)	($0.03)	($0.10)	($0.17)	($0.33)	($0.06)
Adjusted Weighted Average Diluted Shares Outstanding	12.59M	11.97M	16.85M	17.83M	18.42M	19.15M	26.04M	28.75M	30.63M	30.29M	47.09M
Adjusted Basic & Diluted Earnings per Share	$0.00	($1.75)	$0.00	$0.00	$0.00	($0.50)	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	13.40M	0.00	0.00	17.83M	23.35M	0.00	28.75M	30.21M	34.92M	0.00	54.43M
Normalized Net Operating Profit after Tax (NOPAT)	-2.11	-9.51	-1.29	-1.75	-1.57	-6.28	-0.58	-1.85	-1.27	-7.98	-1.53
Normalized NOPAT Margin	-16.47%	-60.05%	-8.81%	-13.26%	-12.63%	-44.13%	-4.25%	-12.56%	-7.44%	-40.52%	-8.53%
Pre Tax Income Margin	-26.63%	-86.84%	-12.80%	-19.62%	-17.59%	-67.09%	-5.97%	-19.18%	-31.28%	-51.49%	-15.65%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-22.41	-40.10	-10.70	-6.86	-11.59	-29.14	-3.86	-4.32	-5.26	-9.84	-2.49
NOPAT to Interest Expense	-14.03	-28.20	-7.62	-5.11	-8.64	-19.63	-3.12	-3.36	-1.46	-8.45	-1.88
EBIT Less CapEx to Interest Expense	-22.52	-40.24	-11.19	-6.96	-12.85	-29.37	-3.93	-4.36	-5.28	-9.85	-2.51
NOPAT Less CapEx to Interest Expense	-14.14	-28.34	-8.11	-5.21	-9.90	-19.86	-3.18	-3.40	-1.48	-8.46	-1.89
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-0.64%	-0.54%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Cosmos Health Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cosmos Health's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Cosmos Health's net income appears to be on an upward trend, with a most recent value of -$19.14 million in 2025, rising from -$6.69 million in 2015. The previous period was -$16.18 million in 2024. See Cosmos Health's forecast for analyst expectations on what's next for the company.

Cosmos Health's total operating income in 2025 was -$16.70 million, based on the following breakdown:

Total Gross Profit: $7.90 million
Total Operating Expenses: $24.60 million

Over the last 10 years, Cosmos Health's total revenue changed from $533.80 thousand in 2015 to $65.27 million in 2025, a change of 12,127.7%.

Cosmos Health's total liabilities were at $47.05 million at the end of 2025, a 58.0% increase from 2024, and a 2,369.4% increase since 2015.

In the past 10 years, Cosmos Health's cash and equivalents has ranged from $38.54 thousand in 2019 to $20.75 million in 2022, and is currently $715.67 thousand as of their latest financial filing in 2025.

Over the last 10 years, Cosmos Health's book value per share changed from -0.01 in 2015 to 0.53 in 2025, a change of -5,429.3%.

Related Companies

Financial statements for NASDAQ:COSM last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cosmos Health (COSM) Financials

Financials Breakdown Chart

Cosmos Health Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cosmos Health (COSM) Financials

Annual Income Statements for Cosmos Health

Quarterly Income Statements for Cosmos Health

Annual Cash Flow Statements for Cosmos Health

Quarterly Cash Flow Statements for Cosmos Health

Annual Balance Sheets for Cosmos Health

Quarterly Balance Sheets for Cosmos Health

Annual Metrics And Ratios for Cosmos Health

Quarterly Metrics And Ratios for Cosmos Health

Financials Breakdown Chart

Cosmos Health Financials - Frequently Asked Questions

When does Cosmos Health's fiscal year end?

How has Cosmos Health's net income changed over the last 10 years?

What is Cosmos Health's operating income?

How has Cosmos Health's revenue changed over the last 10 years?

How much debt does Cosmos Health have?

How much cash does Cosmos Health have?

How has Cosmos Health's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools